QR Kodea

Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Refractory Mycobacterium avium Complex Lung Disease in Real-World Settings

Atsuho Morita,1 Ho Namkoong,2 Kazuma Yagi,1 Takanori Asakura,1 Makoto Hosoya,3 Hiromu Tanaka,1 Ho Lee,1 Takunori Ogawa,1 Tatsuya Kusumoto,1 Shuhei Azekawa,1 Kensuke Nakagawara,1 Hirofumi Kamata,1 Makoto Ishii,1 Koichi Fukunaga,1 Hiroyuki Ozawa,3 Naoki Hasegawa2 1Division of Pulmonary Medicine, Depar...

Deskribapen osoa

Gorde:
Egile Nagusiak: Morita A, Namkoong H, Yagi K, Asakura T, Hosoya M, Tanaka H, Lee H, Ogawa T, Kusumoto T, Azekawa S, Nakagawara K, Kamata H, Ishii M, Fukunaga K, Ozawa H, Hasegawa N
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2022-07-01
Saila:Infection and Drug Resistance
Gaiak:
mycobacterium avium complex
mac
nontuberculous mycobacteria
ntm
amikacin liposome inhalation suspension
alis
Sarrera elektronikoa:https://www.dovepress.com/early-phase-adverse-effects-and-management-of-liposomal-amikacin-inhal-peer-reviewed-fulltext-article-IDR
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak